PL1817326T3 - Przemysłowy sposób wytwarzania γ-laktonu kwasu 17-hydroksy-6ß,7ß,15ß,16ß-bismetylen-3-okso-17α-pregn-4-eno-21-karboksylowego i kluczowe związki pośrednie dla tego sposobu - Google Patents
Przemysłowy sposób wytwarzania γ-laktonu kwasu 17-hydroksy-6ß,7ß,15ß,16ß-bismetylen-3-okso-17α-pregn-4-eno-21-karboksylowego i kluczowe związki pośrednie dla tego sposobuInfo
- Publication number
- PL1817326T3 PL1817326T3 PL05797354T PL05797354T PL1817326T3 PL 1817326 T3 PL1817326 T3 PL 1817326T3 PL 05797354 T PL05797354 T PL 05797354T PL 05797354 T PL05797354 T PL 05797354T PL 1817326 T3 PL1817326 T3 PL 1817326T3
- Authority
- PL
- Poland
- Prior art keywords
- beta
- bismethylene
- pregn
- lactone
- ene
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- LHPNCDWEQHATRO-UNUXFHLRSA-N 3-[(8s,9s,10r,13r,14s,17r)-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl]propanoic acid Chemical compound C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)CCC(O)=O)[C@@H]4[C@@H]3CCC2=C1 LHPNCDWEQHATRO-UNUXFHLRSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
- C07J53/008—3 membered carbocyclic rings in position 15/16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Reproductive Health (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyrane Compounds (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Polyesters Or Polycarbonates (AREA)
- Lubricants (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0402465A HUP0402465A2 (en) | 2004-11-30 | 2004-11-30 | Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main intermediates of the process |
| PCT/HU2005/000110 WO2006059167A1 (en) | 2004-11-30 | 2005-10-11 | INDUSTRIAL PROCESS FOR THE PREPARATION OF 17-HYDROXY-6β,7β;15β,16β-BISMETHYLENE-3-OXO-17α-PREGN-4-ENE-21-CARBOXYLIC ACID Ϝ-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS |
| EP05797354A EP1817326B1 (en) | 2004-11-30 | 2005-10-11 | Industrial process for the preperation of 17-hydroxy -6 beta, 7-beta, 15-beta, 16-beta-bismethylene-3-oxo 17-alpha pregn-4-ene-21-carboxylic acid gamma-lactone and key intermediates for this process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1817326T3 true PL1817326T3 (pl) | 2010-10-29 |
Family
ID=89985651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05797354T PL1817326T3 (pl) | 2004-11-30 | 2005-10-11 | Przemysłowy sposób wytwarzania γ-laktonu kwasu 17-hydroksy-6ß,7ß,15ß,16ß-bismetylen-3-okso-17α-pregn-4-eno-21-karboksylowego i kluczowe związki pośrednie dla tego sposobu |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8309712B2 (pl) |
| EP (1) | EP1817326B1 (pl) |
| JP (1) | JP4971179B2 (pl) |
| CN (1) | CN101061133B (pl) |
| AT (1) | ATE468349T1 (pl) |
| AU (1) | AU2005311059B2 (pl) |
| CA (1) | CA2585802C (pl) |
| CY (1) | CY1110098T1 (pl) |
| DE (1) | DE602005021395D1 (pl) |
| DK (1) | DK1817326T3 (pl) |
| ES (1) | ES2345560T3 (pl) |
| HK (1) | HK1107354A1 (pl) |
| HU (1) | HUP0402465A2 (pl) |
| PL (1) | PL1817326T3 (pl) |
| PT (1) | PT1817326E (pl) |
| SI (1) | SI1817326T1 (pl) |
| WO (1) | WO2006059167A1 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20042338A1 (it) * | 2004-12-06 | 2005-03-06 | Ind Chimica Srl | Processo per la preparazione di drospirenone |
| SI2019114T1 (sl) * | 2007-07-26 | 2011-04-29 | Newchem S P A | Postopek za pripravo drospirenona |
| US7960368B2 (en) * | 2008-03-05 | 2011-06-14 | Everstra, Inc. | Bismethylene-17A carbolactones and related uses |
| WO2010068500A2 (en) * | 2008-11-25 | 2010-06-17 | Evestra, Inc. | PROGESTATIONAL 3-(6,6-ETHYLENE-17b-HYDROXY-3-OXO-17a-PREGNA-4-ENE-17a -YL) PROPIONIC ACID g-LACTONES |
| US8334375B2 (en) * | 2009-04-10 | 2012-12-18 | Evestra, Inc. | Methods for the preparation of drospirenone |
| DE102009031909B4 (de) * | 2009-07-01 | 2017-02-09 | Heyl Chemisch-Pharmazeutische Fabrik Gmbh & Co. Kg | Verfahren zur Herstellung von Drospirenon aus Prasteron |
| DE102009031908B4 (de) * | 2009-07-01 | 2017-02-09 | Heyl Chemisch-Pharmazeutische Fabrik Gmbh & Co. Kg | Verfahren zur Herstellung von Drospirenon aus 15-Hydroxyandrostendion |
| DE102009038972A1 (de) * | 2009-08-23 | 2011-06-30 | Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG, 14167 | Verfahren zur Herstellung von Drospirenon aus 6,7,15,16-Dimethylenandrost-4-en-3,17-dion |
| DE102009031907B4 (de) * | 2009-07-01 | 2017-02-09 | Heyl Chemisch-Pharmazeutische Fabrik Gmbh & Co. Kg | Verfahren zur Herstellung von Drospirenon aus Androstendion |
| CN109232700B (zh) * | 2018-09-17 | 2020-06-26 | 宁波三生生物科技有限公司 | 一种烯丙孕素的高效合成方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH539621A (de) * | 1966-04-02 | 1973-07-31 | Schering Ag | Verfahren zur Herstellung von 15,16B-Methylensteroiden |
| CH510002A (de) * | 1968-04-22 | 1971-07-15 | Hoffmann La Roche | Verfahren zur Herstellung neuer Pregnene |
| DE2652761C2 (de) * | 1976-11-16 | 1985-11-21 | Schering AG, 1000 Berlin und 4709 Bergkamen | 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| DE2746298A1 (de) * | 1977-10-13 | 1979-04-19 | Schering Ag | 4-androsten-3,17-dion-derivate, ihre herstellung und verwendung |
| DE3042136A1 (de) * | 1980-11-03 | 1982-06-09 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur herstellung von 3 (beta), 7 (beta) -dihydroxy- (delta) (pfeil hoch)5(pfeil hoch) -steroiden |
| DE3265852D1 (en) * | 1981-09-21 | 1985-10-03 | Schering Ag | 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-17-one, its 3,15-dipivalate, and its preparation |
| DE19633685C1 (de) * | 1996-08-12 | 1997-10-09 | Schering Ag | Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens |
-
2004
- 2004-11-30 HU HU0402465A patent/HUP0402465A2/hu unknown
-
2005
- 2005-10-11 PL PL05797354T patent/PL1817326T3/pl unknown
- 2005-10-11 DK DK05797354.7T patent/DK1817326T3/da active
- 2005-10-11 US US11/719,333 patent/US8309712B2/en active Active
- 2005-10-11 JP JP2007543936A patent/JP4971179B2/ja active Active
- 2005-10-11 SI SI200531046T patent/SI1817326T1/sl unknown
- 2005-10-11 DE DE602005021395T patent/DE602005021395D1/de active Active
- 2005-10-11 EP EP05797354A patent/EP1817326B1/en active Active
- 2005-10-11 AT AT05797354T patent/ATE468349T1/de active
- 2005-10-11 WO PCT/HU2005/000110 patent/WO2006059167A1/en active Application Filing
- 2005-10-11 CA CA002585802A patent/CA2585802C/en active Active
- 2005-10-11 ES ES05797354T patent/ES2345560T3/es active Active
- 2005-10-11 PT PT05797354T patent/PT1817326E/pt unknown
- 2005-10-11 AU AU2005311059A patent/AU2005311059B2/en active Active
- 2005-10-11 CN CN2005800398624A patent/CN101061133B/zh active Active
-
2008
- 2008-02-01 HK HK08101261.2A patent/HK1107354A1/xx unknown
-
2010
- 2010-06-17 CY CY20101100558T patent/CY1110098T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2345560T3 (es) | 2010-09-27 |
| AU2005311059B2 (en) | 2011-01-06 |
| EP1817326A1 (en) | 2007-08-15 |
| DE602005021395D1 (de) | 2010-07-01 |
| CN101061133B (zh) | 2011-01-26 |
| HU0402465D0 (en) | 2005-01-28 |
| HK1107354A1 (en) | 2008-04-03 |
| CN101061133A (zh) | 2007-10-24 |
| WO2006059167A1 (en) | 2006-06-08 |
| ATE468349T1 (de) | 2010-06-15 |
| EP1817326B1 (en) | 2010-05-19 |
| PT1817326E (pt) | 2010-06-25 |
| US20080200668A1 (en) | 2008-08-21 |
| JP4971179B2 (ja) | 2012-07-11 |
| JP2008521875A (ja) | 2008-06-26 |
| CA2585802A1 (en) | 2006-06-08 |
| CY1110098T1 (el) | 2015-01-14 |
| US8309712B2 (en) | 2012-11-13 |
| DK1817326T3 (da) | 2010-08-30 |
| HUP0402465A2 (en) | 2006-07-28 |
| AU2005311059A1 (en) | 2006-06-08 |
| SI1817326T1 (sl) | 2010-08-31 |
| CA2585802C (en) | 2009-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1817326T3 (pl) | Przemysłowy sposób wytwarzania γ-laktonu kwasu 17-hydroksy-6ß,7ß,15ß,16ß-bismetylen-3-okso-17α-pregn-4-eno-21-karboksylowego i kluczowe związki pośrednie dla tego sposobu | |
| UA95644C2 (ru) | Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний | |
| EP3812372A3 (en) | 7-heterocyclyl substituted sancycline derivatives for treating bacterial, viral and parasitic infections (e.g. malaria) or inflammatory diseases | |
| GEP20146055B (en) | Inhibitors of renal outer medullary potassium channel | |
| WO2009111653A3 (en) | Antiviral therapeutic agents | |
| HK1111168A1 (en) | A PROCESS FOR THE PREPARATION OF 17-HYDROXY-6 ß,7ß,15 ß,16 ß - BISMETHYLENE-17a-PREGN-4-ENE-3-ONE-21-CARBOXYLIC ACID Y-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS | |
| MX339476B (es) | Compuestos que incluyen un nucleo farmaceutico antiinflamatorio y sus metodos de uso. | |
| MX2009004746A (es) | Derivados de 1,2,4-triazol como inhibidores del receptor sigma. | |
| TW200745122A (en) | New compounds I | |
| MY143581A (en) | Carboxamide derivatives as muscarinic receptor antagonists | |
| TW200716564A (en) | Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
| NO20084301L (no) | Tetrahydronaftalenderivater, fremgangsmate for deres fremstilling og anvendelse derav som anti-inflammatoriske midler | |
| TW200621703A (en) | Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
| MX2008011576A (es) | Compuestos de imidazo[2,1-b]tiazol sustituidos y su uso para la produccion de farmacos. | |
| TW200745133A (en) | New compounds II | |
| TW200738611A (en) | 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments | |
| TW200716555A (en) | Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
| DE602007005387D1 (de) | Ptors | |
| TW200510323A (en) | Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives | |
| ATE377020T1 (de) | Kristallines gamma-lacton der17beta-hydroxy- | |
| ATE425948T1 (de) | Substituierte hydroxyacetophenonderivative | |
| WO2010131118A3 (en) | Polymorphs of etravirine and processes for preparation thereof | |
| TW200700389A (en) | 5h-benzocycloheptene derivatives, process for their production and their use as anti-inflammatory agents | |
| WO2009110938A3 (en) | Novel macrocyclic polyene lactams | |
| MX2011008239A (es) | Composicion farmaceutica solida que contiene sulfamato de 6-oxo-6,7,8,9,10,11-hexahidrociclohepta[c]cromen-3-ilo y sus polimorfos. |